Do reductions in risk of cardiorenal events with SGLT2 inhibitors in type 2 diabetes vary with baseline characteristics? A meta-analysisMei Qiu,Shu-Yan Liu,Jin-Song Gu,Kai-Kai Li,Ling-Lin Li,Liang-Liang DingEndocrine(2020)引用 7|浏览0暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要